Latest Nature Communications Study: AI-Enabled Development of Next-Generation ENPP1 Inhibitors for Innate Immune Modulation by Insilico Medicine (IMAGE)

InSilico Medicine

Latest Nature Communications Study: AI-Enabled Development of Next-Generation ENPP1 Inhibitors for Innate Immune Modulation by Insilico Medicine

Caption

Discovery and Development of ISM5939

Credit

Insilico Medicine

Usage Restrictions

N/A

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.